0 items USD 0.00Search
- Did you mean
- closing spondylitis
Your search for "Ankylosing%20spondylitis" gave back 267 results.
Aciclofenac is a new, strong antipyretic, analgesic, anti-arthritis drugs, clinically applicable to the treatment of rheumatoid arthritis, rheumatoid...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Humira is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. The global Humira...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Etanercept, sold under the brand name Enbrel among others, is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis...
Catalog:
LPI
March 2023
Price: USD 3,660.00
A rising elderly population and increasing allocations for research and development of new drugs is what is serving to drive growth in the global...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Enthesopathy is derived from a combination of entheso means a specific structure within the musculoskeletal system and pathy means presence of...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Dexibuprofen is a nonsteroidal anti-inflammatory drug. It is the active dextrorotatory enantiomer of ibuprofen. Most ibuprofen formulations contain a...
Catalog:
GIR
January 2023
Price: USD 4,480.00
The global Humira Biosimilar market size is projected to grow from US$ 411.8 million in 2022 to US$ 966.9 million in 2029; it is expected to grow at...
Catalog:
LPI
June 2023
Price: USD 3,660.00
The “Anti-TNF-α Monoclonal Antibody Industry Forecast” looks at past sales and reviews total world Anti-TNF-α Monoclonal Antibody sales in 2022,...
Catalog:
LPI
March 2023
Price: USD 3,660.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
Catalog:
LPI
February 2023
Price: USD 3,660.00
TNF (tumor necrosis factor) inhibitors are anti-inflammatory drugs. TNF inhibitors help to block the TNF alpha that occurs naturally in the body and...
Catalog:
LPI
February 2023
Price: USD 3,660.00
Etoricoxib is a non-steroidal anti-inflammatory drug (NSAID) that explicitly targets enzymes responsible for inflammation and pain namely...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The “Arthritic Therapeutic Industry Forecast” looks at past sales and reviews total world Arthritic Therapeutic sales in 2022, providing a...
Catalog:
LPI
February 2023
Price: USD 3,660.00
The global Infliximab Biosimilar market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (...
Catalog:
GIR
March 2023
Price: USD 4,480.00
